Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5983_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
6 Мб
Скачать
☆
178
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
regions (3′
are stem-loop structures transcribed in the nucleus by RNA polymerase


     


         
-
 




2018).

6.3 NANOTECHNOLOGY IN GENE DELIVERY

6.3.1 PROPERTIES OF NANOPARTICLES FOR AN EFFICIENT GENE
DELIVERY

  



        
 


      
capacity to deliver many components at once (Wong et al., 2017). Induced
       
 -



in Figure 6.1.
Nanotechnology in Gene Delivery
179
FIGURE 6.1 
6.3.2 PRECLINICAL STUDIES OF NANOPARTICLES USED IN GENE
DELIVERY

-
-


   

180
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

-




-







FIGURE 6.2 

-
   
     
       
area. Polyethylenimine (PEI), polyethylene glycol (PEG), polylysine (PLL),
Nanotechnology in Gene Delivery
181
TABLE 6.1 Nanoparticles-Mediated Gene Delivery.
Nanoparticles Gene delivered Applications Reference
Polymer
nanoparticles
Polyethylenimine  
threonine kinase1 mRNA


apoptosis
Muthiah et al., 2015


and bone morphogenetic
protein 2
Bone regeneration Curtin et al., 2015
 
virus thymidine kinase and
granulocyte-macrophage

Antitumor activity Alekseenko et al.,
2015
pDNA  Lee et al., 2015
Polylysine pDNA Lung gene therapy Suk et al., 2014
Poly(lactic-coglycolic acid) AntimiR-10b and
antimiR-21
Breast cancer therapy Devulapally et al.,
2015
Poly(beta-amino ester) pDNA Glioblastoma treatment 
 siRNA 
nucleic acids
Borgheti-Cardoso,
2015
Dendrimer
nanoparticles
 siRNA Cervical cancer therapy Ionov et al., 2015
 pDNA Breast cancer therapy Figueroa et al., 2014
 pDNA  An et al., 2013
Carbosilane-Ammonium Oligonucleotides Liver gene therapy De las Cuevas et al.,
2012
182
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Nanoparticles Gene delivered Applications Reference
 miRNA Enhanced cell

Gray et al., 2013
 pDNA  Wang et al., 2015
Solid-lipid
nanoparticles
 siRNA Breast cancer therapy Hu et al., 2013
   
Solid lipid nanoparticles -protamine pDNA  
al., 2012
Carbon-based
nanoparticles


pDNA Enhanced

Qin et al., 2011


pDNA Antitumor activity Karmakar et al.,
2011
 siRNA Neuroprotection Al-Jamal et al.,
2011


siRNA
pDNA
Antitumor activity Varkouhi et al.,
2011
Graphene

pDNA Vasculogenesis and
cardiac repair
Paul et al., 2014
Ceramic
nanoparticles
 pDNA Enhanced

Wang et al., 2008
Mesoporous

pDNA Enhanced gene

Park et al., 2008
 pDNA Enhanced gene

Choi et al., 2008
TABLE 6.1
(Continued)
Nanotechnology in Gene Delivery
183
Nanoparticles Gene delivered Applications Reference
Gadolinium-oxide-doped silica
nanoparticles
pDNA Enhanced gene

Bhakta et al., 2011
3-(Aminopropyl)trimethoxysilane

pDNA Enhanced gene

Chen et al., 2005


pDNA Enhanced gene

Namgung et al.,
2011
Metallic
nanoparticles
 miRNA  Ghosh et al., 2013
 pDNA  Shan et al., 2012
 Oligonucleotides  Kim et al., 2012
 siRNA  Heinemann et al.,
2013
 siRNA  Conde et al., 2015
TABLE 6.1
(Continued)
184
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
poly(lactic-coglycolic acid) (PLGA), and poly(b-amino ester) (PBAE) are

2017).
Studies conducted both in vivo and in vitro have demonstrated the ability
     
-

      

  




   -
-
blastoma-targeting gene therapy using the retro-inverso C-end rule peptide



-
           




  










Nanotechnology in Gene Delivery
185
repetitively branched nanoparticles. Convergent or divergent synthesis can

  

           
      
cationic dendrimers, including PAMAM, carbosilane, and phosphorus. Both


      


   

         
(Wang et al., 2015).
-
linking agents 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochlo-






  


     
(Han et al., 2014). Other dendrimers, including carbosilane, have proven

Cuevas et al., 2012).





186
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
       
         
vectors (Wong et al., 2017).
       



given to in vivo-
      -
gated micelles containing pDNA are given to MCF-7 cells or mice carrying
the A549 human pulmonary carcinoma (Hu et al., 2013). A three-layered

DNA distribution has been examined (Nomoto et al., 2014). Another study



   





     



Delivering siRNA targeted against procollagena1(I) has been studied as
    
        



Carbon-based nanoparticles are used in gene delivery and they include carbon
p53 gene is used
-
    
Nanotechnology in Gene Delivery
187
        
             

-1
. Standard ethidium bromide and acridine orange




-

      
     





         

        
motor cortex caused by an endothelin-1-induced stroke model, peri-lesional
 -



    


acid delivery have been conducted. Due to their nano-needle structure, they
are expected to pass through the plasma membrane and enter the cytoplasm
        
        
      
       



   
      
        